Baxter to Divest Vantive Kidney Care to the Carlyle Group for $3.8B
Pending regulatory approval, this transfer to a global investment company will take place in late 2024 or early 2025. Baxter will use the proceeds to pay down debt.
Read the full article » | Posted 08-16-2024
Related Articles
- In August 2026, 70 nephrology fellows were chosen for the 2026–2027 ASN Home Dialysis Scholarship Program Posted 09-18-2026
- Dialysis Act would give patients more stability, options, Atlanta Journal-Constitution, August 28, 2026 Posted 09-18-2026
- NKF Survey Sheds Light on Work Responsibilities and More Posted 07-16-2026
- Home HD Now Offered in Croatia Posted 07-16-2026